F A Eskens Selected Research

Carcinogenesis

10/2000

Farnesyl transferase inhibitors: current developments and future perspectives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F A Eskens Research Topics

Disease

5	Neoplasms (Cancer) 07/2001 - 05/2000
1	Oligodendroglioma 07/2001
1	Bone Resorption 07/2001
1	Vomiting 02/2001
1	Diarrhea 02/2001
1	Fatigue 02/2001
1	Nausea 02/2001
1	Anorexia 02/2001
1	Neutropenia 02/2001
1	Thrombocytopenia (Thrombopenia) 02/2001
1	Carcinogenesis 10/2000

Drug/Important Bio-Agent (IBA)

2	Matrix Metalloproteinases (MMPs)IBA 07/2001 - 01/2001
2	TransferasesIBA 02/2001 - 10/2000
2	EnzymesIBA 01/2001 - 10/2000
1	Temozolomide (Temodar)FDA LinkGeneric 07/2001
1	Urokinase Plasminogen Activator ReceptorsIBA 07/2001
1	CathepsinsIBA 07/2001
1	CGS 27023AIBA 07/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2001
1	CytokinesIBA 07/2001
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2001
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 07/2001
1	Tissue Inhibitor of Metalloproteinase-1IBA 07/2001
1	Tissue Inhibitor of Metalloproteinase-2IBA 07/2001
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 07/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2001
1	Matrix Metalloproteinase InhibitorsIBA 07/2001
1	lonafarnib (SCH 66336)IBA 02/2001
1	CreatinineIBA 02/2001
1	Oncogene Proteins (Oncogene Protein)IBA 10/2000
1	PolyaminesIBA 05/2000
1	4-amidinoindan-1-one 2'-amidinohydrazone (CGP 48664)IBA 05/2000

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 07/2001
1	Drug Tapering 02/2001